Novo Nordisk A/S
NVO · Large Cap · NYSE · Healthcare · Drug Manufacturers - General
$39.03−$0.41 (-1.03%)
Market closed · opens in 1d 0hNext open: Monday, Oct 26, 9:30 AM ETFree AI brief
Get the full brief on NVO
Free to track. No card required. Usually ready in 10-15 minutes.
Where NVO sits today
Price, momentum, and the numbers behind the story.
RSI (14)
62.5Neutral
03070100
Stocksbrew score
53/100
See the full financial picture
Open the five-year record, valuation checks and Wall Street view behind these scores.
- ✓5 years of revenue, profit and cash flow
- ✓Valuation and balance-sheet checks
- ✓Business and geographic mix
- ✓Analyst targets and recommendation trend
Free for 3 days, then $9/mo. Cancel anytime.
What Wall Street thinks
Where the analysts and the crowd stand, and what it's worth to know first.
Analyst price targets
Current price
$39.03
Lowest
$39.9
Median target
$43.46
Highest
$62.03
LowHigh
The business, by the numbers
What it earns and where it earns it, what you're paying for the stock, and the risk sitting on the balance sheet.
RevenueTrend
✓ Good things about the company
Forward P/E
Favorable · 38% below avg
11.75x
Price / FCF
Strong · Cash flow supports price
15.15x
EV / EBITDA
Strong · Earnings support price
7.05x
ROIC
Strong · Excellent capital returns
39.2%
ROE
Favorable · 59.8% - strong capital efficiency
59.8%
Debt / equity
Favorable · 0.63 - strong leverage
0.63x
⚠ Things to watch
Current ratio
Weak · Low cash for bills
0.87x
How it stacks up against its peers
NVO against the names it's actually compared to.
| Company | Mkt cap | P/E | Rev growth | Score |
|---|---|---|---|---|
| $129.92B | 9.5 | +5.6% | 53 |
 | $10.93B | 20.8 | +19.7% | 78 |
 | $29.41B | 30.8 | +15.5% | 78 |
 | $4.30B | 12.2 | +13.5% | 78 |
 | $1.20T | 43.3 | +49.6% | 77 |
What is moving NVO
Every story that touched the stock this week, newest first.